Table 5.
Opinion of Peace Corps Medical Officers regarding accessibility and type of rabies immune globulin (RIG), and the accessibility and type of rabies vaccine for postexposure prophylaxis (PEP) of non-Peace Corps volunteer travelers in their country of station, 2011
| West, Central, and East Africa | Eastern Europe and Northern Asia | Tropical South America | Mexico, Central America, and Caribbean | East and Southeast Asia | North Africa and Middle East | Southern Africa | Indian Ocean | Total | |
|---|---|---|---|---|---|---|---|---|---|
| In the country where you were stationed in 2011, how often was RIG accessible* when it was needed for travelers? | |||||||||
| Number of responses | 12 | 6 | 4 | 5 | 3 | 2 | 2 | 1 | 35 |
| Never, n (%) | 4 (33) | 1 (17) | 3 (75) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 9 (26) |
| Seldom, n (%) | 2 (17) | 2 (33) | 0 (0) | 2 (40) | 1 (33) | 1 (50) | 1 (50) | 0 (0) | 9 (26) |
| Sometimes, n (%) | 2 (17) | 2 (33) | 1 (25) | 2 (40) | 1 (33) | 1 (50) | 0 (0) | 1 (100) | 10 (29) |
| Often, n (%) | 4 (33) | 1 (17) | 0 (0) | 0 (0) | 1 (33) | 0 (0) | 0 (0) | 0 (0) | 6 (17) |
| Always, n (%) | 0 (0) | 0 (0) | 0 (0) | 1 (20) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2.8) |
| In the country in which you were stationed during 2011, what type of RIG was used for rabies PEP? | |||||||||
| Number of responses | 8 | 5 | 1 | 5 | 3 | 2 | 1 | 1 | 28 |
| Human RIG, n (%) | 3 (38) | 2 (40) | 1 (100) | 2 (40) | 2 (67) | 0 (0) | 0 (0) | 0 (0) | 10 (39) |
| Equine RIG, n (%) | 0 (0) | 1 (20) | 0 (0) | 0 (0) | 2 (67) | 0 (0) | 0 (0) | 0 (0) | 3 (12) |
| Other, n (%) | 1 (13) | 0 (0) | 0 (0) | 2 (40) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (12) |
| I don't know, n (%) | 4 (50) | 3 (60) | 0 (0) | 1 (20) | 0 (0) | 2 (100) | 1 (100) | 1 (100) | 12 (46) |
| In the country where you were stationed in 2011, how often was rabies vaccine accessible* when it was needed for travelers? | |||||||||
| Number of responses | 12 | 6 | 4 | 5 | 3 | 2 | 2 | 1 | 35 |
| Never, n (%) | 0 (0) | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2.9) |
| Seldom, n (%) | 2 (17) | 1 (17) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (8.6) |
| Sometimes, n (%) | 3 (25) | 0 (0) | 1 (25) | 2 (40) | 0 (0) | 1 (50) | 0 (0) | 1 (100) | 8 (23) |
| Often, n (%) | 4 (33) | 5 (83) | 1 (25) | 2 (40) | 3 (100) | 0 (0) | 0 (0) | 0 (0) | 15 (43) |
| Always, n (%) | 3 (25) | 0 (0) | 1 (25) | 1 (20) | 0 (0) | 1 (50) | 2 (100) | 0 (0) | 8 (23) |
| In the country where you were stationed in 2011, what type of rabies vaccine was used as a part of PEP for rabies? | |||||||||
| Number of responses | 12 | 6 | 3 | 5 | 3 | 2 | 2 | 1 | 34 |
| Vero cell, n (%) | 7 (58) | 3 (50) | 3 (100) | 3 (60) | 2 (67) | 2 (100) | 2 (100) | 1 (100) | 23 (68) |
| Human diploid cell, n (%) | 3 (25) | 1 (17) | 0 (0) | 2 (40) | 1 (33) | 0 (0) | 0 (0) | 0 (0) | 7 (21) |
| Purified chick embryo cell, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (67) | 0 (0) | 0 (0) | 0 (0) | 2 (5.9) |
| Other, n (%) | 1 (8.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2.9) |
| Don't know, n (%) | 1 (8.3) | 3 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (12) |
*
“Accessible” was defined as available within 24 hours.